Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42]

Affiliations

• ¹ Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, University of Naples Federico II, Napoli, Italy. Electronic address: spadaro@unina.it.
• ² AOU Careggi, SOD Immunoallergologia, Firenze, Italy.
• ³ AOU Careggi, SOD Ematologia, Firenze, Italy.
• ⁴ Onkologie, Westerstede, Germany.
• ⁵ Onkologische Praxis, Aurich, Germany.
• ⁶ Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research, University of Naples Federico II, Napoli, Italy.
• ⁷ Department of Molecular Medicine, "Sapienza" University of Rome, Italy.
• ⁸ Clinical Development & Operations, Kedrion S.p.A., Castelvecchio Pascoli, Lucca, Italy.